"
Palbociclib in First-Line vs Second-Line Treatment for HR+/HER2− Metastatic Breast Cancer: Real-World Evidence from a Moroccan Cohort"
written by Chaymae Chbihi, Hafssa El Hilali, Samia El Hakym, Diango Keita, Sara Nejjari, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi, Nawfel Mellas,
published by
Journal of Cancer Therapy,
Vol.17 No.2, 2026
has been cited by the following article(s):